002107 Stock Overview
Manufactures and sells pharmaceutical products in China. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Shandong Wohua Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥5.02 |
52 Week High | CN¥7.22 |
52 Week Low | CN¥3.20 |
Beta | 0.23 |
11 Month Change | 8.89% |
3 Month Change | 34.22% |
1 Year Change | -24.40% |
33 Year Change | -21.44% |
5 Year Change | 9.28% |
Change since IPO | 67.89% |
Recent News & Updates
Shareholder Returns
002107 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -2.1% | -5.2% | -4.1% |
1Y | -24.4% | -6.7% | 3.8% |
Return vs Industry: 002107 underperformed the CN Pharmaceuticals industry which returned -6.7% over the past year.
Return vs Market: 002107 underperformed the CN Market which returned 3.8% over the past year.
Price Volatility
002107 volatility | |
---|---|
002107 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 7.2% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002107 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002107's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 1,353 | Yingzi Zeng | www.wohua.cn |
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers tablets, hard capsules, granules, powders, and pills, such as honeyed, water, and concentrated pills. The company also produces and sells oral liquids, mixtures, liquors, tinctures, decoctions, and syrups, as well as patent medicines; and provides medical technology consulting services.
Shandong Wohua Pharmaceutical Co., Ltd. Fundamentals Summary
002107 fundamental statistics | |
---|---|
Market cap | CN¥2.85b |
Earnings (TTM) | CN¥24.28m |
Revenue (TTM) | CN¥769.79m |
119.4x
P/E Ratio3.8x
P/S RatioIs 002107 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002107 income statement (TTM) | |
---|---|
Revenue | CN¥769.79m |
Cost of Revenue | CN¥219.39m |
Gross Profit | CN¥550.40m |
Other Expenses | CN¥526.13m |
Earnings | CN¥24.28m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.042 |
Gross Margin | 71.50% |
Net Profit Margin | 3.15% |
Debt/Equity Ratio | 0% |
How did 002107 perform over the long term?
See historical performance and comparison